Inhaled stem cells could repair lungs in COPD – first human trial begins
NCT ID NCT06986070
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether inhaling small mobile stem cells (SMS) is safe for people with mild to moderate COPD. 18 participants aged 39–69 will receive the cells via a nebulizer. The study focuses on safety and side effects, not yet on whether the treatment works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Small Mobile Stem Cells (SMS cells) inhaled via nebulizer
What this could lead to
If safe, this could pave the way for a new treatment that helps repair lung damage in COPD patients.
What could go wrong
This is a very early, first-in-human trial with only 18 people. The main goal is safety, not effectiveness. Stem cell treatments carry unknown risks, and the therapy may not work as hoped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC OBSTRUCTIVE LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Doherty Clinical Trials Limited
NOT_YET_RECRUITINGMelbourne, Victoria, 3002, Australia
-
Veritus Research
RECRUITINGBayswater, Victoria, 3153, Australia